Company Profiles

driven by the PitchBook Platform

Acesion Pharma

Acesion Pharma
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.52M LATEST DEAL AMOUNT
$3.82M TOTAL AMOUNT RAISED
Description

Developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
Ole Maaløes Vej 3
2200 Copenhagen N
Denmark

+45 2044 2073
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acesion Pharma’s full profile, request a free trial.

Acesion Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 17-Dec-2014 $2.52M $3.82M Completed Startup
3. Grant 01-Dec-2013 00.000 00.00 Completed Startup
2. Early Stage VC 05-May-2013 $1.3M $1.3M Completed Startup
1. Seed Round 01-Dec-2011 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Acesion Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Broadview Ventures Venture Capital Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
SEED Capital Denmark Venture Capital Minority 000 0000 000000 0
Wellcome Trust Limited Partner 000 0000 000000 0

Acesion Pharma Executive Team (7)

Name Title Board
Seat
Contact
Info
Frans Wuite MD Chief Executive Officer
Jakob Dynnes Hansen Chief Financial Officer
Ulrik Sørensen Ph.D Chief Operating Officer & Co-Founder
Morten Grunnet Ph.D Co-Founder & Chief Scientific Officer & Board Member
Christina Sylvest Senior Vice President, Acute Cardioversion
You’re viewing 5 of 7 executives. Get the full list »

Acesion Pharma Board Members (8)

Name Representing Role Since Contact
Info
Carsten Schou Ph.D SEED Capital Denmark Board Member 000 0000
Christopher De Souza Ph.D Broadview Ventures Board Observer 000 0000
Ingelise Saunders Self Chairman 000 0000
Lars Gredsted Ph.D Acesion Pharma Board Member 000 0000
Paul Goldenheim MD Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »